Apixaban Use Among Patients With Severe Renal Impairment

Abstract

Get full access to this article

View all access options for this article.

References

Eliquis [package insert, p6]. Princeton, NJ: Bristol-Myers Squibb; 2014.

Granger

Alexander

McMurray

. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992. doi:10.1056/NEJMoa1107039.

Agnelli

Buller

Cohen

. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799-808. doi:10.1056/NEJMoa1302507.

Wang

Song

Tirucheraiet

. Apixaban pharmaco-kinetics in subjects with end-stage renal disease on hemodialysis. Poster presented at: 2012 American College of Clinical Pharmacology Annual Meeting; September 23-25, 2012; San Diego, CA.

Tsai

Maddox

Roe

. Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventions. JAMA. 2009;302:2458-2464. doi:10.1001/jama.2009.1800.